Form 4: Mind Medicine (MindMed) CEO Receives Stock Grant
Insider Transaction (Form 4)
Robert Barrow, Chief Executive Officer and a Director of Mind Medicine (MindMed) Inc., received 375,000 shares of common stock on August 12, 2026.
Summary
- Grant/award: acquired 375,000 Common Shares on August 12, 2026; holds 1,473,246 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Robert Barrow — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-12 | Grant/award | Common Shares | 375,000 | — | — | 1,473,246 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-12 | Grant/award (375,000 shares) |
Keywords
insider transaction, Form 4, DFTX, Definium Therapeutics, Inc., neutral, Robert Barrow
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.